Literature DB >> 9737661

Pattern of expression of tetraspanin antigen genes in Burkitt lymphoma cell lines.

M Ferrer1, M Yunta, P A Lazo.   

Abstract

Tetraspanin antigens are implicated in the prognosis of different types of tumours. In this study we determine by semiquantitative reverse transcriptase-polymerase chain reaction (RT-PCR) the level of 13 tetraspan messages in 21 Burkitt lymphoma (BL) cell lines. All tumour cell lines have a common pattern of tetraspanin gene expression. There are five antigens which are detected in 90% of cell lines at high levels, CD53, CD81, CD63, SAS and CD82. Another two, CD9 and CD37, were detected in 60% of cell lines, and have a very variable level of expression. The remaining antigens, A15, CoO29, KRAG, L6, TI-1 and il-TMP, are expressed at low levels in very few cell lines without any specific pattern. The level of gene expression corresponds with the level of cell surface antigen determined by flow cytometry. The average number of tetraspan proteins expressed per cell line is six. These proteins may form subunits of an oligomeric structure with 24 transmembrane domains. There are no major differences in tetraspan expression pattern among sporadic or endemic tumours, type of translocation or Epstein-Barr virus status, suggesting the original cell of these tumours is the same, probably a late pre-B cell, at the CD9 to CD37 transition point. Tetraspanin gene expression is consistent with BL being a single entity, despite variations in other parameters.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9737661      PMCID: PMC1905070          DOI: 10.1046/j.1365-2249.1998.00670.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  41 in total

1.  Molecular cloning and characterization of an antigen associated with early stages of melanoma tumor progression.

Authors:  H Hotta; A H Ross; K Huebner; M Isobe; S Wendeborn; M V Chao; R P Ricciardi; Y Tsujimoto; C M Croce; H Koprowski
Journal:  Cancer Res       Date:  1988-06-01       Impact factor: 12.701

Review 2.  Novel structurally distinct family of leucocyte surface glycoproteins including CD9, CD37, CD53 and CD63.

Authors:  V Horejsí; C Vlcek
Journal:  FEBS Lett       Date:  1991-08-19       Impact factor: 4.124

Review 3.  Connexin family of gap junction proteins.

Authors:  E C Beyer; D L Paul; D A Goodenough
Journal:  J Membr Biol       Date:  1990-07       Impact factor: 1.843

4.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

5.  Cross-linking of CD53 promotes activation of resting human B lymphocytes.

Authors:  A M Rasmussen; H K Blomhoff; T Stokke; V Horejsi; E B Smeland
Journal:  J Immunol       Date:  1994-12-01       Impact factor: 5.422

6.  The protein CD63 is in platelet dense granules, is deficient in a patient with Hermansky-Pudlak syndrome, and appears identical to granulophysin.

Authors:  M Nishibori; B Cham; A McNicol; A Shalev; N Jain; J M Gerrard
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

7.  Mammalian uroplakins. A group of highly conserved urothelial differentiation-related membrane proteins.

Authors:  X R Wu; J H Lin; T Walz; M Häner; J Yu; U Aebi; T T Sun
Journal:  J Biol Chem       Date:  1994-05-06       Impact factor: 5.157

Review 8.  The biology of erbB-2/neu/HER-2 and its role in cancer.

Authors:  N E Hynes; D F Stern
Journal:  Biochim Biophys Acta       Date:  1994-12-30

9.  Induction of nitric oxide release by MRC OX-44 (anti-CD53) through a protein kinase C-dependent pathway in rat macrophages.

Authors:  L Boscá; P A Lazo
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

10.  Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA.

Authors:  S Ikeyama; M Koyama; M Yamaoko; R Sasada; M Miyake
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

View more
  4 in total

1.  Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma.

Authors:  Zijun Y Xu-Monette; Ling Li; John C Byrd; Kausar J Jabbar; Ganiraju C Manyam; Charlotte Maria de Winde; Michiel van den Brand; Alexandar Tzankov; Carlo Visco; Jing Wang; Karen Dybkaer; April Chiu; Attilio Orazi; Youli Zu; Govind Bhagat; Kristy L Richards; Eric D Hsi; William W L Choi; Jooryung Huh; Maurilio Ponzoni; Andrés J M Ferreri; Michael B Møller; Ben M Parsons; Jane N Winter; Michael Wang; Frederick B Hagemeister; Miguel A Piris; J Han van Krieken; L Jeffrey Medeiros; Yong Li; Annemiek B van Spriel; Ken H Young
Journal:  Blood       Date:  2016-10-19       Impact factor: 22.113

2.  Promotion of bone morphogenetic protein signaling by tetraspanins and glycosphingolipids.

Authors:  Zhiyu Liu; Herong Shi; Lindsey C Szymczak; Taner Aydin; Sijung Yun; Katharine Constas; Arielle Schaeffer; Sinthu Ranjan; Saad Kubba; Emad Alam; Devin E McMahon; Jingpeng He; Neta Shwartz; Chenxi Tian; Yevgeniy Plavskin; Amanda Lindy; Nimra Amir Dad; Sunny Sheth; Nirav M Amin; Stephanie Zimmerman; Dennis Liu; Erich M Schwarz; Harold Smith; Michael W Krause; Jun Liu
Journal:  PLoS Genet       Date:  2015-05-15       Impact factor: 5.917

Review 3.  CD151-A Striking Marker for Cancer Therapy.

Authors:  Seema Kumari; Gayatri Devi; Anil Badana; Venkata Ramesh Dasari; Rama Rao Malla
Journal:  Biomark Cancer       Date:  2015-03-22

4.  Identification of a novel drug lead that inhibits HCV infection and cell-to-cell transmission by targeting the HCV E2 glycoprotein.

Authors:  Reem R Al Olaby; Laurence Cocquerel; Adam Zemla; Laure Saas; Jean Dubuisson; Jost Vielmetter; Joseph Marcotrigiano; Abdul Ghafoor Khan; Felipe Vences Catalan; Alexander L Perryman; Joel S Freundlich; Stefano Forli; Shoshana Levy; Rod Balhorn; Hassan M Azzazy
Journal:  PLoS One       Date:  2014-10-30       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.